Compensation plans that incorporate incentive schemes act as a sales force motivator. This study deals with sales force compensation plans from a management perspective, in the South African pharmaceutical industry. A literature review of incentive schemes is provided. Results are reported about the compensation plans and incentive schemes of 38 organisations. The design, implementation, and evaluation of sales force compensation and incentive schemes are discussed. Guidelines for the development of sales force incentive schemes are provided.
Introduction
The cost of a sales force is rising and is by far the largest element in a company's marketing expenditure. A survey of the South African pharmaceutical industry in 1978 found that the sales force cost between 40 and 75% of the company's marketing budget (Flint, 1991 ) . Therefore companies need to ensure that their sales forces are highly productive and motivated. As a result, companies consequently try to improve the productivity of their sales force through better selection, training, motivation and compensation. Of these, compensation and incentive schemes play an important role in motivating sales people to perform better.
The purpose of this study was to investigate compensation plans and incentive schemes of pharmaceutical companies operating in South Africa. There are very few studies on sales management issues in the pharmaceutical industry worldwide. Richardson, Swan & Mcinnis-Bower (1994) and Bush & Grant ( 1994) analysed the content of four leading marketing and sales journals for a 17-and 13-year period respectively. Only 2.6% of the articles were on the topic of compensation and 9.7% of the articles dealt with the pharmaceutical industry (Richardson, Swan & Mcinnis-Bower, 1994) . In addition, the size of the industry warrants research of this nature.
The South African Pharmaceutical industry is dominated by foreign companies. According to the Pharmaceutical Manufacturers Association of South Africa, more than 30% of domestic demand for pharmaceuticals is imported. Imports grew in nominal figures from R501.8 million in 1990 to R1282.7 million in 1995, an increase of 155%. The total pharmaceutical market in 1995 was R4594 million of which the prescription market accounted for 75.3% of the total (PMA, 1997) .
In summary, the purpose of this study was to analyse incentive schemes in operation, and to draw up guidelines that will assist sales management with the future design of incentive plans.
Context Motivation and compensation
Compensation deals with every type of reward individuals receive in exchange for performing organisational tasks. Employees can be paid for the time they work, their skills and knowledge, the output they produce, and competencies or a combination of these factors (lvancevich, 1998) . Variable pay has become a popular method of payment as it links reward to performance or productivity (Smith, 1992) . Methods for paying employees on the basis of output are usually referred to as incentive forms of compensation. Pay motivates job performance to the extent that merit increases and other work-related rewards are allocated on the basis of performance (Milkovich & Newman, 1990) .
Motivation is the set of attributes and values that predisposes a person to act in a specific, goal-directed manner (lvancevich, 1998) . Motivation at work has been identified as occurring in two ways: intrinsic motivation is derived from job content, and can be described as the process of motivation by work itself in so far as it meets people's needs or leads to the expectation that their goals will be achieved (Flude, 1992) . People seek the type of work that satisfies them, and intrinsic motivation is therefore self-generated. Extrinsic motivation refers to what is done for people to motivate them. It arises from the provision by management of rewards such as salary increases and promotion. Extrinsic motivators are said to have an immediate and powerful effect, but may not be long lasting (Armstrong & Murlis, 1994) . This review will be concerned primarily with extrinsic motivation of the sales force.
The specific nature of the sales job together with the personality of the sales person, the diversity of company goals, and the changing character of market conditions greatly influence the motivation level and therefore the performance of sales representatives {Ingram, Schwepker & Hudson, 1992; Steinbrink, 1978) .
Most sales people rate monetary rewards as the best motivator (Walker, Churchill & Ford, 1977; Bagozzi, 1980; Berry & Abrahamsen, 1981; Churchill & Pecotich, 1982; Churchill, Ford & Walker, 1993) . In a South African survey, most sales executives use incentive payments predominantly to motivate their sales representatives (Abratt & Smythe, 1989) . A sales person's job satisfaction is seen by both sales representatives and sales management as a key motivator (Winer & Schiff, 1980; Jackson & Hisrich, 1996; Doyle & Shapiro, 1980; Churchill, Ford & Walker, 1997) .
The design, implementation, evaluation and regular adjustments of incentive plans is an important task for management. In a survey of more than 400 industrial firms in the United States, more than one third of them were unhappy with their incentive programs (Churchill, Ford & Walker, 1993 ) . Sales management has to decide on three basic compensation plans for its sales force, a salary-only plan, a commission-only plan, or a combination plan (Steinbrink, 1978; Jackson & Hisrich, 1996; Churchill, Ford & Walker, 1997) . The literature states that there are advantages to all types of plans as well as disadvantages (Steinbrink, 1978; Jackson & Hisrich, 1996; Churchill, Ford & Walker, 1997; Stanton, Buskirk & Spiro, 1995) . The straight salary plan is useful for missionary selling tasks or when the allocation of sales results to a single sales representative is not easy. The straight commission plan is useful for companies that are only interested in improving sales volume or profitability.
The most widely used plan is a combination of base salary and financial incentives, such as commission, bonus or sales contests (Churchill, Ford & Walker, 1997; Barnes, 1986) . A combination plan is useful for companies that are interested in both selling activities and non-selling duties, such as customer service and new account management.
Sales quotas can be defined as specific goals set for sales people who are made responsible for attaining them over a specific period of time. The ime p_riod is usually one year (Good & Stone, 1991) .
Quotas are used as the basis for paying out incentives (Churchill, Ford & Walker 1997; Barnes, 1986; Dubinsky & Barry, 1982) . The most important kind of quota is sales volume. Only a minority of firms use qualitative measures, such as morale and loyalty (Dubinsky & Barry, 1982; Churchill, Ford & Walker, 1997) . In most companies, incentive payment is only due when a sales per-on reaches I 00% of their quota (Barnes, 1986) .
Many companies use incentive caps or ceilings on potential compensation. This policy limits costs, but can also have a negative impact on the motivation of sales people with outstanding performance. Sales people who achieve much more than I 00% of quota would therefore be prevented from receiving deserved rewards (Barnes, 1986) . Many researchers believe that sales incentive schemes loose their effectiveness over time and should therefore be updated regularly. This is mainly due to changing market conditions (Churchill & Pecotich, 1982) . Incentive plans should be reviewed at least once a year or when required (Barnes, 1986; Jackson & Hisrich, 1996; Lidstone, 1978) .
Many different compensation packages are in use for sales forces in different industries. The results of previous studies can be summarised as follows. Most companies use a combination incentive plan. Only a few use a salary-only or a commission-only scheme (Barnes, 1986; Churchill, Ford & Walker, 1997; Steinbrink, 1978) . The most widely used com-S AfrJ Bus. Managc.1999JO(J) bination plan is salary plus commission. Over the last 30 years the incentive proportion of the sales compensation plan has increased (Barnes, 1986 : Churchill. Ford & Walker, 1997 -Stanton, Buskirk & Spiro. 1995 . The majority of sales repre'. sentatives prefer a combination plan consisting of a base salary plus a form of incentive (Ingram. Schwepker & Hutson 1992; Winer & Schiff. 1980) . ' Non-financial rewards consist mainly of promotion opportunities, recognition programs and programs to improve self. esteem. They are long-term additional motivators for sales representatives (Bagozzi. 1980 : Churchill. Ford & Walker, 1997 Futrell, Parasuraman & Sagar. 1983 ) Non-financial rewards are mainly seen as less important than financial incentives. Specifically designed programs to enhance a sales representative's motivation via non-financial rewards are not used very often (Steinbrink, 1978 : Winer & Schiff, 1980 . For Bagozzi, non-financial rewards are at least as important as monetary incentives (Bagozzi, 1980) . A balanced combination of both methods can enhance motivation and therefore the performance of sales people.
Research propositions
The literature review leads to the formulation of five propositions for this study. Pl: Sales force incentive schemes are part of the compensation package of most pharmaceutical companies (Barnes, 1986; Churchill, Ford & Walker, 1993; Steinbrink, 1978; Winer & Schiff, 1980) . P2:A combination of base salary, commission and sales con· tests is the most fre,,uently practiced type of a sales force compensation package within the pharmaceutical industry (Barnes, 1986; Churchill, Ford & Walker, 1993; Ingram, Schwepker & Hudson, 1992 : Steinbrink, 1978 . P3:The main reason for companies to use incentive schemes is to motivate their sales force (Bagozzi, 1980 : Berry & Abrahamsen, 1981 : Churchill & Pecotich, 1982 ; Church· ill, Ford & Walker, 1993 : Doyle & Shapiro, 1980 : Jackson & Hisrich, 1996 : Ingram, Schwepker & Hudson, 1992 . P4:0nly a minority of pharmaceutical companies use non· financial rewards as additional motivators for sales people (Bagozzi, 1980 : Churchill, Ford & Walker, 1993 Futrell, Parasuraman & Sagar, 1983 : Steinbrink 1978 : Winer & Schiff, 1980 . P5:Most companies have fixed intervals for updating incen· tive schemes of one year or longer ( Barnes, 1986 : Church· ill & Pecotich, 1982 : Churchill, Ford & Walker, 1993 Jackson & Hisrich, 1996 : Lidstone, 1978 .
Methodology
The research procedure was to take the following steps. A literature review was undertaken to understand the theory and to summarise prior research. The questionnaire was designed from previous studies and tuen tested in a pilot study. The pilot study was conducted on four managers from different pharmaceutical companies. They were asked for feedback on the content of the questionnaire and how long it took to complete as well as the numerit.:al values of the questions. As a result, some minor changes were made. The sample was determined as the entire population of South Afric'.1'1 pharmaceutical companies. The questionnaire, together with a fax cover sheet and a personal covering letter were then faxed to the sample. Follow-up calls were undertaken ten to 14 days later. The completed questionnaires were then processed using appropriate analytical procedures.
Questionnaire design
The questionnaire in the Abratt & Smythe (1989) survey was used as a basis for this study, but it was modified slightly to reflect the specific issues of the pharmaceutical industry as well as current issues. The questionnaire was divided into four sections. The first asked for specific company data, the second the design of incentive schemes, the third was the management of incentive schemes, and the fourth was a set of open-ended questions.
The questionnaire was piloted on respondents from four different pharmaceutical companies.
The respondents were asked for feedback regarding the content of the questionnaire, the time it took to complete, and specifically the ranges of numerical values of several questions. As a result of this exercise several minor changes were made to the questionnaire. The questionnaire appeared easy to complete and took on average between 15 and 20 minutes.
Sample
The population for this study consisted of sales and marketing managers or human resources managers of all pharmaceutical companies in South Africa who are responsible for the development of sales force compensation schemes. The lists of members of the National Association of Pharmaceutical Manufacturers as well as the Pharmaceutical Manufacturers' Association were used. These reflected a total of 185 different companies. Most of these belonged to larger parent companies. Therefore, only companies with individual sales policies were included in the universe. These consisted of 62 separate pharmaceutical companies.
Data analysis
The questionnaire consisted of fixed alternative questions and open-ended questions. The questions were edited and coded before the responses were coded. A well-known computer software package was used to tabulate the responses. Frequency distributions, percentages, measures of central tendency and dispersion were derived from simple tabulations. The data were entered twice to ensure accuracy. The openended questions were analysed by content analysis. The answers were categorised and the responses counted. This led to a set of nominal data which were then analysed.
Results

Profile of respondents
Of the 62 companies in the sample 39 companies responded. One questionnaire had to be discarded because of a lack of completeness and consistency. Thus a total of 38 usable replies were received resulting in a response rate of 61.3%. A profile of the respondents is shown in Table I .
The majority of companies were subsidiaries of foreign companies, mostly from the United States and Germany. Only 21.1 % of respondents were South African owned. The prescription medicine sector is the most important market for the majority of companies. More than half of all companies were large with annual sales volumes of RI 00 million or more, and employed sales forces of more than 21 sales representatives.
Compensation plans
The pharmaceutical companies used many different compensation plans. These are shown in Table 2 . All companies used a combination plan with a base salary plus one or more incentives. The most important single plan was salary plus group bonus plus commission plus sales contest, followed by salary plus commission.
In addition to salary and incentives, the sales representatives receive other benefits. These are additional payments to satisfy sales people's security needs. These are shown in Table 3.
All firms offered their sales representatives a company car or a car scheme. Most companies offered medical aid, a cellular phone, a pension scheme, an expense allowance and disability insurance. Most companies saw benefits as additional standard industry payments to their employees and thus not as an incentive itself.
The driving factors for the use of incentive schemes by the respondents are shown in Table 4 .
The most important reasons companies used sales incentives were to motivate the sales force, and to direct the efforts of the sales force. The least important factor was to make the sales force work harder. Thus, organisations use incentives to influence behaviour positively, not only to increase performance, but also to reward them appropriately. Because motivation of the sales force was found by Abratt & Smythe ( 1989) as the most important reason why companies use incentive schemes, respondents were asked to rank motivating factors in order of importance. These are shown in Table 5 .
Self-satisfaction in doing a good job was rated as the most important factor with satisfying customer needs as the second most important. The two least important factors were to keep one's job and to improve one's lifestyle. These results are in line with the findings of Winer & Schiff ( 1980) . One must note that these findings reflect the opinion of managers, not that of salespeople.
Companies were asked to indicate how the increase in base salary for their sales representative were determined. Altogether 79% based salary increase on a performance appraisal. The fair market rate was used by 50% of the respondents and 24% took cost of living rises into account.
The time a sales person has worked for a company was not seen as a criterion to determine salary increases at all.
Incentive schemes
As far as the allocated responsibility for the design of incentive schemes are concerned, the three people mainly involved were the sales manager (92. l %), the general manager (73.7%) and the marketing manager. The human resources department was generally not involved in the design of incentive schemes. The sales staff were also consulted by very few firms (5.2%). This is surprising because Stanton et al. ( 1995) suggests that management should solicit suggestions from the sales force regarding a compensation plan. Sales people are more likely to accept a plan if they were consulted about it during its design and development.
Respondents were asked to indicate what measures they used to establish incentive payments. This is shown in Table  6 .
The three most important measures were 'sales above a target', 'company performance', and 'different rates by product category'. Very few companies used 'market infor· mation' as a basis for incentive payments. The results show that managers believe that the major driving force for use in incentive schemes is to motivate the sales force (Table 4) . Only 34.2% of the managers noted that incentives were de· signed to increase sales per sales person. However, the most important measure used for incentive payments, was 'sales above target' (Table 6) . This points at an anomaly in the sense that management has a hidden agenda when they pur· portedly want to 'motivate' sales people. Companies that pay their sales representatives for customer, competitor and other information may have an advantage in the market place. Morale was not seen as an important factor, perhaps due to the problem of quantifying it. Stanton et al. ( 1995) states that high morale is of great importance for sales forces to achieve excellent results.
The gross earnings of sales representatives as well as the split between salary and incentives is shown in Table 7 .
There was a broad range in the annual average gross earnings of sales representatives. The two most popular salary maximums were RI 00 000 and R 120 000. The large differences in compensation payments were possibly due to a lack of industry information. Companies seem to have no knowledge of competitors' compensation plans. All respondents made use of a combination plan with a fixed salary portion and an incentive portion. The most popular split was 80% salary, 20% incentive, followed by 90/10 and 70/30. These findings clearly show that the majority of pharmaceutical firms do not use a high incentive proportion of total payment. This may be due to the specific working conditions of pharmaceutical sales representatives. They sell products which demand a higher level of knowledge and more time to educate and inform customers. Thus non-selling activities are more important than in some other industries.
Most of the respondents used ceilings on incentive payments.Sixty-one percent of the companies stated that their incentive ceiling was 40% of base salary.
Altogether 17% used a ceiling of 60% and 4% used a ceiling of a I 00%; 18% had a ceiling of over a I 00%.
Bonuses are an important aspect of sales incentive plans. Seventy-three percent of respondents used bonuses as an incentive. Bonuses were paid out quarterly by 57% of firms, annually by 29% and monthly by 14%. To be effective motivators, bonus payments should be paid out shortly after a sales representative reaches the necessary performance or quota. The ideal payment frequency of bonuses would therefore be a payment every month.
Many researchers stress the importance of non-financial rewards as additional motivators for salespeople (Churchill, Ford & Walker, 1997; Futrell, Parasuraman & Sagar, 1983; Bagozzi, 1980; Steinbrink, 1978) .
Only 34% of respondents actually used this kind of incentive. The most important type of non-monetary incentive was recognition programmes. Companies using them could therefore attain a competitive advantage in the market place through higher motivated and better performing sales representatives. Incentives schemes need to be reviewed and up· dated as market conditions change. Most firms in the sample (71.1 %) reviewed compensation plans on an annual basis, 13.2% reviewed them as required and 7.9% reviewed them quarterly. The rest reviewed their compensation plans semiannually.
!
Management of incentive schemes
The respondents were asked to give their opinion on issues of management and implementation of incentive schemes.
More than 60% of all companies emphasised that sales management have flexibility with regard to the issue of incentive awards. Flexibility is important to meet unforeseeable situations which are out of the control of the sales representative.
These situations like production problems or supply problems can affect the individual performance of sales people negatively and can make quota attainment impossible. Eighty-three percent of the respondents stated that targets must be strictly achieved for incentives to be earned, and 97% No answer 5 132 mentioned top management support for sales incentive schemes. Management also recognised the potential negative side effects of incentive schemes. This is shown in Table 8 .
The three most often mentioned negative side effects were 'neglect of other products', 'some staff not participating' and the 'overstocking of customers'. The reason for some staff not participating is that they don't buy into the system as they perceive it as unfair or not well designed. Most of these can be prevented by designing incentive plans with secondary and tertiary goals, such as special incentives for non-selling duties like administrative work, or additional incentives for less important product lines.
Monitoring of the sales force and evaluation of compensation plans Monitoring or supervision of sales representatives is an essential management task and is aimed to provide training and assistance, enforcement, better performance and improved morale. According to Stanton et al. ( 1995) several techniques can be called 'automatic supervisory techniques'. These include the compensation plan. This is by far the most important automatic supervisory tool because it encourages representatives to do those things that will maximise their earnings. Table 9 shows the methods management use to monitor their sales forces.
The most common methods employed to monitor or to supervise the sales force were 'meeting sales objectives, turnover against set targets, call rate, and market share'. Qualitative methods, such as 'customer relations ' and,. t . , m~ nal relations were not used often. The criteria used to evaluate the effectiveness of ince t" h . h . T bl n IVe sc emes 1s s own m a e I 0.
The main criterion used by 84.2% of all respondents w 'measurement against budget'. Other criteria used by 47.45: of the sample were sales per product before versus after th introduction of sales incentives. and total sales before vers; after the introduction of sales incentives.
Research propositions and results
The findings will be tied to the set propositions.
Pl: Sales force incentive schemes are part of the compensation package of most pharmaceutical companies. Incentives were found to be part of the compensation package of all pharmaceutical firms. All companies used a combination plan with a base salary and one or more incentives. Thus proposition one is supported.
P2:A combination of base salary. commission and sales contests is the most frequently practised type of a sales force compensation package within the pharmaceutical industry. The single most important type of incentive plan was 'salary, plus group bonuses plus commission plus sales contest'. Only 13.2% of respondents used a combination of base salary, commission and sales contests. Thus proposition two has little support. P3: The main reason for companies to use incentive schemes is to motivate their sales force. The reason mentioned most often as to why pharmaceutical firms used incentive schemes was indeed to motivate their sales people. Proposition three is therefore supported.
P4:0nly a minority of pharmaceutical companies use non-financial rewards as additional motivators for sales people. The findings showed that 34.2% of respondents used non· financial rewards. Proposition four is thus supported. P5:Most companies have fixed intervals for updating incen· tive schemes of one year or longer. Most companies (71. I%) updated their incentive plans on an annual basis. Thus proposition five can be supported.
Discussion and implications
There is clearly no single sales incentive plan that is suitable for all pharmaceutical firms. However, many. important generic principles of a sound compensation plan have been found. A well-designed scheme is able to improve the sales force's performance and productivity. Support from top management and other management functions is crucial for the success of incentive plans.
Sales staff should participate in the design phase of incen· tive plans. The plan should be designed according to industry standards and company requirements.
A successful sales incentive scheme needs to be planned properly. The following steps in designing a plan should be adhered to:
I. Assess the firm's marketing and sales objectives, account management policies, and current performance of the sales force. Qualitative perfonnance measures such as morale, product knowledge, customer satisfaction, and reporting style should be quantifiable, for example via a JO-point scale ranging from very poor to excellent. The total incentive payments should be linked to total sales, that is a specific percentage. This will ensure that there is an economic relationship between sales costs and sales volume. The base salary increases should be primarily based on perfonnance appraisals. However, the experience and education of sales representatives should also be of importance. There should be no limits on incentive payments.
Extraordinary achievements should be rewarded with extraordinary payments. The best perfonners of the sales force would then be further motivated to reach even more stretching goals and can thereby be prevented from leaving the company.
Incentive schemes should be simple and uncomplicated to ensure that sales people do not have difficulties in understanding them, see the relationship between efforts and rewards, and are able to calculate what their incomes will be. Incentive schemes should be designed to be perceived as fair and equitable. Sales management should only base rewards on measurable perfonnance and use non-measurable behaviour for the annual review of base salary. The compensation plans should be flexible to meet the needs of individual territories, products, customers and sales representatives. Nonfinancial rewards should be used as additional low cost incentives. Specifically designed programs to enhance recognition and self-esteem of sales representatives should be established. Incentive schemes must be clearly documented by a written statement to make it clear for every sales person beforehand what he or she will have to do to earn a specific reward.
Conclusion
This study shows that South African pharmaceutical firms have realised the importance of sales compensation plans for the success of their sales forces. All companies used incentives as motivators for their sales representatives.
The broad variety of different incentive plans in use and the lack of infonnation about competitor compensation schemes 71 seems to be due to the lack of a structured 'scientific' design and the implementation of such plans. An attempt has been made to remedy this situation by recommending an approach for management to use when designing sales compensation plans.
